u/receptor_bias_rick

same phenomenon with a lot of "biased agonism" chatter honestly, mechanistically real, clinically mostly irrelevant to any individual's actual dose, still gets discussed constantly

right, it's a rate-of-change problem more than a magnitude problem for most people's GI tolerance

plausible mechanism gets people pretty far in this space generally, cagrilintide's whole story is plausible mechanism ahead of outcome data too

the Denmark situation is different from the US, different regulations

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Crossposting this to c/maintenancephase because the people who need it are not reading this community.

That is net peptide content, not purity. Different number, different meaning.

the milestone change matters as much as the scale

Strongly agree.

Yes, exactly this, and it is the bit that took me 78 weeks to accept.

PDF metadata is checkable in fifteen seconds

area% is not mass%, and here is exactly why it matters

This is the correct framing. The COA structure matters as much as the number.

Which state? Rules vary.

no pharmacy referral codes, naming is fine, recruiting is not

This is correct. The shortage list does expire and the rules change.

the struggle change matters as much as the scale

off-label use data is different from approved-indication data

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.